Search For "pfi"
US FDA approves emergency use of Pfizer-BioNTech vaccine for children in 1
Updated : 4 years, 10 months ago IST
Washington [US], May 11 (ANI): The US Food and Drug Administration (FDA) on Monday (local time) authorised the emergency use of the Pfizer-BioNTech COVID-19 vaccine to children in the age group of 12-15 years.
Read More
Pfizer applies for permit to administer COVID-19 vaccine to teens
Updated : 4 years, 10 months ago IST
Moscow [Russia], May 8 (ANI/Sputnik): US drugmaker Pfizer has applied to Switzerland's medicines regulator for the extension of the use of its coronavirus vaccine to teens of 12-15 years, the watchdog said on Friday.
Read More
Pfizer, BioNTech seek full approval of COVID-19 vaccine across US
Updated : 4 years, 10 months ago IST
Washington [US], May 7 (ANI): Pharmaceutical giants Pfizer and BioNTech on Friday said that they have started the process for getting the US Food and Drug Administration (FDA) complete authorisation of its COVID-19 vaccine after having emergency use authorization for almost five months.
Read More
COVID-19 vaccination associated with fewer asymptomatic SARS-CoV-2 infecti
Updated : 4 years, 10 months ago IST
Washington [US], May 6 (ANI): Vaccination dramatically reduced COVID-19 symptomatic and asymptomatic infections in St. Jude Children's Research Hospital employees compared with their unvaccinated peers, according to a research letter.
Read More
Tokyo Olympics: Pfizer, BioNTech to supply vaccines for athletes
Updated : 4 years, 10 months ago IST
Tokyo [Japan], May 6 (ANI): As part of the plans to ensure safe and secure Olympic and Paralympic Games Tokyo 2020, the International Olympic Committee (IOC) on Thursday announced the signing of a Memorandum of Understanding (MoU) with Pfizer Inc. and its partner BioNTech SE to donate doses
Read More
Mobilising largest humanitarian relief effort to India in wake of COVID-19
Updated : 4 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Pfizer on Monday announced the "largest humanitarian relief effort to India" in the company's history to help India fight the second wave of coronavirus.
Read More
Pfizer in talks with India over expedited approval for COVID-19 vaccine: C
Updated : 4 years, 10 months ago IST
New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India.
Read More
One in four persons experience COVID-19 vaccines' side effects: Study
Updated : 4 years, 11 months ago IST
London [UK], May 1 (ANI): An investigation conducted by analysts at King's College London tracked down that one out of four individuals experience mild, short-lived systemic side effects like cerebral pain, weariness and tenderness after receiving either the Pfizer or AstraZeneca vaccine.
Read More
COVID-19: Committed to continuing to work with India to establish path for
Updated : 4 years, 11 months ago IST
Washington [US], April 30 (ANI): Pfizer and BioNTech are firmly committed to working towards equitable and affordable access for their COVID-19 vaccine for people around the world including in India, the company said in a statement on Friday.
Read More
Indian envoy to US Sandhu holds discussions with Pfizer CEO on COVID-19 re
Updated : 4 years, 11 months ago IST
Washington [US], April 30 (ANI): Indian Ambassador to the US, Taranjit Singh Sandhu on Thursday (local time) met with Pfizer CEO Albert Bouria to discuss ways in which the COVID-19 vaccine maker can support healthcare efforts in India.
Read More
Pfizer's oral drug to stop COVID-19 could be ready next year, says CEO
Updated : 4 years, 11 months ago IST
New York [US], April 28 (ANI): Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year adding the company is working on two antivirals, an oral and an injectable.
Read More
Study: Only one in four people experience mild systemic side effects from
Updated : 4 years, 11 months ago IST
London [UK], April 28 (ANI): One in four people experience mild, short-lived systemic side effects after receiving either the Pfizer or AstraZeneca vaccine, with headache, fatigue and tenderness the most common symptoms, suggest the findings of a new study.
Read More